SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049290
Filing Date
2024-04-26
Accepted
2024-04-26 17:10:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A olma-defa14a-2024_notice.htm DEFA14A 22998
2 GRAPHIC img149946928_0.jpg GRAPHIC 1236823
3 GRAPHIC img149946928_1.jpg GRAPHIC 349529
  Complete submission text file 0000950170-24-049290.txt   2208815
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39712 | Film No.: 24885171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)